<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Alzheimers Res Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">Alzheimers Res Ther</journal-id>
<journal-title-group>
<journal-title>Alzheimer's Research &amp; Therapy</journal-title>
</journal-title-group>
<issn pub-type="epub">1758-9193</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29422088</article-id>
<article-id pub-id-type="pmc">5806294</article-id>
<article-id pub-id-type="publisher-id">344</article-id>
<article-id pub-id-type="doi">10.1186/s13195-018-0344-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chang</surname>
<given-names>Chiung-Chih</given-names>
</name>
<address>
<email>neur099@adm.cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Ya-Ting</given-names>
</name>
<address>
<email>emily0606@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Chi-Wei</given-names>
</name>
<address>
<email>justin1124@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsai</surname>
<given-names>Shih-Jen</given-names>
</name>
<address>
<email>tsai610913@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hsu</surname>
<given-names>Shih-Wei</given-names>
</name>
<address>
<email>hsusw@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Shu-Hua</given-names>
</name>
<address>
<email>sophia4790@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Chen-Chang</given-names>
</name>
<address>
<email>lccs@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Wen-Neng</given-names>
</name>
<address>
<email>cwenneng@cloud.cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lui</surname>
<given-names>Chun-Chung</given-names>
</name>
<address>
<email>lchung3@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lien</surname>
<given-names>Chia-Yi</given-names>
</name>
<address>
<email>u9301024@cgmh.org.tw</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.145695.a</institution-id><institution>Department of Neurology, Cognition and Aging Center, Kaohsiung Chang Gung Memorial Hospital, </institution><institution>Chang Gung University College of Medicine, </institution></institution-wrap>No. 123 Ta-Pei Road, Niaosung, Kaohsiung County 833 Taiwan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0604 5314</institution-id><institution-id institution-id-type="GRID">grid.278247.c</institution-id><institution>Psychiatric Department, </institution><institution>Taipei Veterans General Hospital, </institution></institution-wrap>Taipei, Taiwan </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0425 5914</institution-id><institution-id institution-id-type="GRID">grid.260770.4</institution-id><institution>Psychiatric Division, School of Medicine, </institution><institution>National Yang-Ming University, </institution></institution-wrap>Taipei, Taiwan </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.145695.a</institution-id><institution>Department of Radiology, Kaohsiung Chang Gung Memorial Hospital, </institution><institution>Chang Gung University College of Medicine, </institution></institution-wrap>Kaohsiung, Taiwan </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.145695.a</institution-id><institution>Department of Nuclear Medicine, Kaohsiung Chang Gung Memorial Hospital, </institution><institution>Chang Gung University College of Medicine, </institution></institution-wrap>Kaohsiung, Taiwan </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0637 1806</institution-id><institution-id institution-id-type="GRID">grid.411447.3</institution-id><institution>Division of Medical Imaging, </institution><institution>E-Da Cancer Hospital and I-Shou University, </institution></institution-wrap>Kaohsiung, Taiwan </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>8</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>8</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>10</volume>
<elocation-id>17</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Alzheimer’s disease (AD) is a complex neurodegenerative disease, and genetic differences may mediate neuronal degeneration. In humans, a single-nucleotide polymorphism in the B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2) gene, rs956572, has been found to significantly modulate Bcl-2 protein expression in the brain. The Bcl-2 AA genotype has been associated with reduced Bcl-2 levels and lower gray matter volume in healthy populations. We hypothesized that different Bcl-2 genotype groups may modulate large-scale brain networks that determine neurobehavioral test scores.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Gray matter structural covariance networks (SCNs) were constructed in 104 patients with AD using T1-weighted magnetic resonance imaging with seed-based correlation analysis. The patients were stratified into two genotype groups on the basis of Bcl-2 expression (G carriers, <italic>n</italic> = 76; A homozygotes, <italic>n</italic> = 28). Four SCNs characteristic of AD were constructed from seeds in the default mode network, salience network, and executive control network, and cognitive test scores served as the major outcome factor.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">For the G carriers, influences of the SCNs were observed mostly in the default mode network, of which the peak clusters anchored by the posterior cingulate cortex seed determined the cognitive test scores. In contrast, genetic influences in the A homozygotes were found mainly in the executive control network, and both the dorsolateral prefrontal cortex seed and the interconnected peak clusters were correlated with the clinical scores. Despite a small number of cases, the A homozygotes showed greater covariance strength than the G carriers among all four SCNs.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">Our results suggest that the Bcl-2 rs956572 polymorphism is associated with different strengths of structural covariance in AD that determine clinical outcomes. The greater covariance strength in the four SCNs shown in the A homozygotes suggests that different Bcl-2 polymorphisms play different modulatory roles.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13195-018-0344-4) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Anatomical structural covariance</kwd>
<kwd>Default mode network</kwd>
<kwd>Posterior cingulate cortex</kwd>
<kwd>Executive control network</kwd>
<kwd>Bcl-2</kwd>
<kwd>Polymorphism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005795</institution-id>
<institution>Chang Gung Memorial Hospital, Linkou</institution>
</institution-wrap>
</funding-source>
<award-id>CMRPG8C0571</award-id>
<award-id>CMRPG8D0771</award-id>
<principal-award-recipient>
<name>
<surname>Chang</surname>
<given-names>Chiung-Chih</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001868</institution-id>
<institution>National Science Council</institution>
</institution-wrap>
</funding-source>
<award-id>104-2314-B-182A-026-MY2</award-id>
<principal-award-recipient>
<name>
<surname>Chang</surname>
<given-names>Chiung-Chih</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Background</title>
<p id="Par21">In Alzheimer’s disease (AD), the self-aggregation of amyloid fibrils and accumulation of amyloid plaques represent an important early pathological finding. Whereas the presence of amyloid may trigger downstream network degeneration, the presence of the antiapoptotic protein, B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2), may offer protection by regulating cellular resilience and apoptosis pathways [<xref ref-type="bibr" rid="CR1">1</xref>]. In the mammalian central nervous system, increased expression of Bcl-2 protein has been shown to promote axon regeneration [<xref ref-type="bibr" rid="CR2">2</xref>]. In patients with AD, the overexpression of Bcl-2 protein in surviving glia surrounding amyloid plaques suggests its role against neuroinflammation [<xref ref-type="bibr" rid="CR3">3</xref>]. In addition, nicergoline, a drug that upregulates Bcl-2 protein expression and acts against β-amyloid cascades, has been used clinically to treat age-dependent cognitive impairment [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par22">In humans, a single-nucleotide polymorphism in the Bcl-2 gene, rs956572, has been found to significantly modulate protein and messenger RNA (mRNA) expression levels [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The Bcl-2 AA genotype group has been associated with reduced Bcl-2 levels [<xref ref-type="bibr" rid="CR6">6</xref>]. In bipolar disorders, lower Bcl-2 protein and mRNA levels have been reported in the frontal cortex [<xref ref-type="bibr" rid="CR7">7</xref>]. Subsequent reports in healthy elderly subjects have suggested that genetic variations in Bcl-2 modulate intracerebral structures, including the hippocampus, ventral striatum, and precuneus [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. The AA variant has also been associated with lower gray matter (GM) volume in healthy individuals [<xref ref-type="bibr" rid="CR8">8</xref>]. However, the genetic associations of Bcl-2 on network influences remain to be explored in patients with AD.</p>
<p id="Par23">Recently, resting-state or task-based functional magnetic resonance imaging has been used to map the network connectivity. With subjects in a resting state [<xref ref-type="bibr" rid="CR10">10</xref>], spontaneously correlated low-frequency signal fluctuations occurring within spatially distinct, functionally related cortical-subcortical regions can be measured. One functional network in a task-free state in healthy subjects is referred to as the <italic>default mode network</italic> (DMN), which includes the posterior cingulate cortex (PCC), anterior medial prefrontal cortex, medial temporal lobe, lateral temporal cortex, and inferior parietal lobule. The DMN is regarded to be an early neuroimaging biosignature [<xref ref-type="bibr" rid="CR11">11</xref>], and a recent report suggested that the DMN may be comprised of multiple spatially dissociated but interactive components [<xref ref-type="bibr" rid="CR12">12</xref>], of which two subsystems are of particular interest. The “medial temporal lobe subsystem,” anchored by the entorhinal cortex and the hippocampus, includes the ventral medial prefrontal cortex, posterior inferior parietal lobule, retrosplenial cortex, parahippocampal cortex, and hippocampal formation. This subsystem is involved in mental scene construction and decision making based on retrieval of memory. The “dorsal medial prefrontal cortex subsystem” (or the midline core subsystem) plays a role in self-relevant and affective decision making. It includes the core of the PCC and anterior medial prefrontal cortex, and the cortical hubs of the temporoparietal junction and the lateral temporal and temporal poles.</p>
<p id="Par24">The salience network is anchored by the frontoinsular cortex and dorsal anterior cingulate cortex [<xref ref-type="bibr" rid="CR13">13</xref>]. Enhanced resting-state functional connectivity of the salience network has been reported in patients with AD [<xref ref-type="bibr" rid="CR14">14</xref>], and possible mechanisms have been hypothesized to reflect a compensatory mechanism for the weakened posterior hubs [<xref ref-type="bibr" rid="CR15">15</xref>]. The executive control network (ECN) represents another network that shows increased functional connectivity in patients with AD [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Anchored by the dorsolateral prefrontal cortex (DLPFC), the ECN plays a role in functions such as sustained attention, working memory, and response selection and suppression [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par25">Recent research suggests that regions which are highly related show covariance in morphometric characteristics, so-called structural covariance. It has also been shown that structural covariance patterns are associated with structural or functional connectivity [<xref ref-type="bibr" rid="CR18">18</xref>]. In structural covariance pattern analysis, factors such as genetic variations and developmental, degenerative, and disease staging are important covariates of interest [<xref ref-type="bibr" rid="CR18">18</xref>]. Structural covariance networks (SCNs) can be used to investigate spatial associations of Bcl-2 genotype groups in AD.</p>
<p id="Par26">In this study, we investigated whether the SCN in AD may represent an endophenotype of the Bcl-2 rs956572 genetic polymorphism. Spreng and Turner reported that the Bcl-2 AA genotype may be a risk factor for neuronal apoptosis and oxidative stress [<xref ref-type="bibr" rid="CR19">19</xref>]. Therefore, we stratified our patients according to the Bcl-2 rs956572 genotype as Bcl-2 G carriers (<italic>n</italic> = 76) and A homozygotes (<italic>n</italic> = 28), matched for confounding factors including sex, age, education level, apolipoprotein E4 status, duration of disease, and Mini Mental State Examination (MMSE) score. Because the Bcl-2 genotypes have been reported to influence psychiatric presentation in bipolar disorders [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], we also included Neuropsychiatric Inventory (NPI) scores to evaluate whether the genotype groups affected the behavioral presentations.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Methods</title>
<p id="Par27">This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Chang Gung Memorial Hospital. Both the patients and their caregivers provided written informed consent. The study participants were treated at the Cognition and Aging Center, Department of General Neurology, Kaohsiung Chang Gung Memorial Hospital (male/female ratio, 51/53). Subjects were included on the basis of a consensus of panels composed of neurologists, neuropsychologists, neuroradiologists, and experts in nuclear medicine [<xref ref-type="bibr" rid="CR22">22</xref>]. AD was diagnosed according to the International Working Group criteria [<xref ref-type="bibr" rid="CR23">23</xref>] for a clinical diagnosis of typical AD. The Clinical Dementia Rating scores were 0.5 or 1. All of the patients with AD were under stable treatment with acetylcholinesterase inhibitors from the time of diagnosis. The exclusion criteria were a history of clinical stroke, a modified Hachinski ischemic score &gt; 4 [<xref ref-type="bibr" rid="CR24">24</xref>] and depression.</p>
<sec id="Sec3">
<title>Clinical assessment</title>
<p id="Par28">After enrollment, demographic data and family history were recorded, and physical and neurological examinations were performed. General cognitive function was assessed using the MMSE [<xref ref-type="bibr" rid="CR25">25</xref>]. Verbal and nonverbal episodic memory were assessed using a Chinese version of the Verbal Learning Test [<xref ref-type="bibr" rid="CR26">26</xref>] and the Rey-Osterrieth Complex Figure Test after a 10-minute delay [<xref ref-type="bibr" rid="CR27">27</xref>]. Language screening was performed using the 16-item Boston Naming Test [<xref ref-type="bibr" rid="CR28">28</xref>], a three-step comprehension test, and a semantic verbal fluency test. Visuospatial abilities were assessed using a modified Rey-Osterrieth Complex Figure Test and the number-location test from the Visual Object and Space Perception Battery [<xref ref-type="bibr" rid="CR29">29</xref>]. Frontal lobe function was assessed using digit-forward and backward-span, design fluency, Stroop interference, and modified Trail Making Test B tests [<xref ref-type="bibr" rid="CR30">30</xref>]. For the behavioral observations, we used the 12-item version of the NPI [<xref ref-type="bibr" rid="CR31">31</xref>], with scores ranging from 0 to 144.</p>
</sec>
<sec id="Sec4">
<title>Genotyping</title>
<p id="Par29">Genomic DNA was extracted from blood using a commercial kit (Gentra Puregene Blood Kit; Qiagen, Hilden, Germany), followed by the genotyping procedures for rs956572 using the PCR restriction fragment length polymorphism method [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] The ancestral allele G yielded three bands of 298, 108, and 161 bp, whereas the mutant allele A yielded two bands of 406 and 161 bp. All of the participants’ scores are summarized according to genotype group (G carriers and A homozygotes) in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic characteristics and neuropsychiatric tests between the Bcl-2 A homozygotes and G carriers in Alzheimer’s disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>G carriers (<italic>n</italic> = 76)</th><th>AA (<italic>n</italic> = 28)</th><th><italic>p</italic> Value</th></tr></thead><tbody><tr><td>Age, years</td><td>73.4 (7.6)</td><td>71.8 (7.4)</td><td>0.32</td></tr><tr><td>Education, years</td><td>5.7 (5.4)</td><td>5.4 (5.1)</td><td>0.4</td></tr><tr><td>Sex, male/female</td><td>42/34</td><td>11/17</td><td>0.186</td></tr><tr><td>ApoE ε4 allele-positive cases, <italic>n</italic> (%)</td><td>29 (38.5%)</td><td>13 (46.42%)</td><td>0.503</td></tr><tr><td>Use of rivastigmine/donepezil</td><td>37/39</td><td>17/11</td><td>0.377</td></tr><tr><td>Mini Mental State Examination score</td><td>21.6 (5.7)</td><td>20.6 (5.1)</td><td>0.286</td></tr><tr><td colspan="4">CVVLT verbal memory (9)</td></tr><tr><td> Trials 1–4 total</td><td>19.6 (7.08)</td><td>18.0 (6.9)</td><td>0.173</td></tr><tr><td> 30-second free recall</td><td>4.78 (2.6)</td><td>4.18 (2.73)</td><td>0.265</td></tr><tr><td> 10-minute free recall</td><td>3.52 (3.3)</td><td>3.21(2.8)</td><td>0.935</td></tr><tr><td colspan="4">Visual memory</td></tr><tr><td> Modified Rey-Osterrieth recall (17)</td><td>4.7 (5.2)</td><td>4.04 (4.16)</td><td>0.67</td></tr><tr><td colspan="4">Visuospatial function</td></tr><tr><td> Modified Rey-Osterrieth copy (17)</td><td>14.3 (5.0)</td><td>14.9 (4.6)</td><td>0.896</td></tr><tr><td> Visual Object and Space Perception Battery (10)</td><td>6.4 (3.16)</td><td>5.8 (3.45)</td><td>0.446</td></tr><tr><td colspan="4">Speech and language ability</td></tr><tr><td> Semantic fluency: animal (1 minute)</td><td>11.2 (4.63)</td><td>10.33 (5.74)</td><td>0.387</td></tr><tr><td> Boston Naming Test (15)</td><td>12.8 (3.0)</td><td>11.6 (2.8)</td><td>0.04<sup>a</sup></td></tr><tr><td> Comprehension (4)</td><td>2.8 (0.9)</td><td>2.3 (1.2)</td><td>0.053</td></tr><tr><td colspan="4">Executive function</td></tr><tr><td> Digit backward</td><td>3.2 (1.3)</td><td>3.2 (1.1)</td><td>0.758</td></tr><tr><td> Stroop interference correct (1 minute)</td><td>25.9 (13.1)</td><td>21.6 (15.7)</td><td>0.178</td></tr><tr><td> Design fluency</td><td>4.31 (2.8)</td><td>4.5 (3.8)</td><td>0.612</td></tr><tr><td> Trail Making Test time (&lt;120 seconds)</td><td>99.2 (32.3)</td><td>93.0 (37.9)</td><td>0.446</td></tr><tr><td> Correct line in Trail Making Test (14)</td><td>7.1 (5.4)</td><td>7.6 (5.6)</td><td>0.742</td></tr></tbody></table><table-wrap-foot><p><italic>CVVLT</italic> Chinese Version Verbal Learning Test</p><p>Data are presented as mean (SD); numbers in parentheses following task name are maximal scores</p><p><sup>a</sup><italic>p</italic> &lt; 0.05, Mann-Whitney <italic>U</italic> test</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec5">
<title>Image acquisition</title>
<p id="Par30">Magnetic resonance images were acquired using a 3.0-T magnetic resonance imaging (MRI) scanner (Excite; GE Medical Systems, Milwaukee, WI, USA). Structural images were acquired for structural covariance analysis using the following protocols: a T1-weighted, inversion recovery-prepared, three-dimensional, gradient-recalled acquisition in a steady-state sequence with repetition time/echo time/inversion time of 8600 milliseconds/minimal/450 milliseconds, a 256 × 256-mm field of view, and a 1-mm slice sagittal thickness with a resolution of 0.5 × 0.5 × 1 mm<sup>3</sup>.</p>
</sec>
<sec id="Sec6">
<title>Data analysis</title>
<p id="Par31">Image preprocessing and statistical analysis were performed using SPM12 statistical parametric mapping (<ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm/">http://www.fil.ion.ucl.ac.uk/spm/</ext-link>; Wellcome Trust Centre of Cognitive Neurology, University College London, London, UK). The T1-weighted images were reoriented, realigned, and normalized with the standard Montreal Neurological Institute space. The images were then segmented into GM and white matter. Affine-registered tissue segments were used to create a custom template using diffeomorphic anatomical registration using the exponentiated lie algebra approach. This approach represents one of the highest-ranking registration methods in patients with AD [<xref ref-type="bibr" rid="CR32">32</xref>]. The modulated and warped images were then smoothed with a Gaussian kernel of 8 mm FWHM.</p>
</sec>
<sec id="Sec7">
<title>SCN analysis</title>
<p id="Par32">To investigate the SCNs, regional GM volumes of 4 regions of interest (ROIs) were extracted from the 104 preprocessed images. The seed ROI included the right entorhinal cortex (coordinates 25, −9, −28), left PCC (coordinates −2, −36, 35), right frontoinsular cortex (coordinates 38, 26, −10), and right DLPFC (coordinates 44, 36, 20). The main purpose of this study was to delineate the topography of SCN in terms of Bcl-2 functional polymorphism rather than to report the SCN differences constructed from the right or left seed. Because pathology or functional connectivity in typical AD is also distributed symmetrically, we did not perform a contralateral seed analysis in this study. According to the literature, these seed regions anchor the DMN medial temporal subsystem (right entorhinal cortex) [<xref ref-type="bibr" rid="CR33">33</xref>], DMN midline core subsystem (left PCC) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], salience network (right frontoinsular cortex), and ECN (right DLPFC) [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par33">From the modified GM images, the GM volumes of a 4-mm radius sphere around the seed ROI coordinates were calculated, followed by four separate correlation analyses using the extracted GM volumes as the covariates of interest. The patients with AD, G carriers, and A homozygotes were modeled separately. During the construction of the SCNs, the seed volumes were entered as independent variables, and age, MMSE scores, and total intracranial volumes were entered as covariates to control for confounding from the aging process and disease severity. For each group, specific contrasts were set to identify, for each seed ROI, voxels that showed positive correlations within each group (AA and G carriers). The results reflected the SCNs of each group and were thresholded at <italic>p</italic> &lt; 0.05, corrected for a false discovery rate (FDR). Considering the physiological meanings of the SCN clusters and the disproportionate number of cases in two genotype groups, we reported only the significant clusters showing a cluster size &gt; 100 voxels (337.5 mm<sup>3</sup>). Because the experiment was exploratory, the threshold cutoff was set to avoid reporting clusters showing a spatial extent smaller than the predefined size. Meanwhile, to understand whether the distributions of SCN were driven by the number of cases, we also performed SCN in three genotype groups for qualitative comparisons.</p>
<p id="Par34">Furthermore, to understand how genetic variance may interfere with the structural covariance patterns, voxels showing significant differences in the regression slopes in each ROI were compared, pointing to possible interactions between AA &lt; G carriers or AA &gt; G carriers. The threshold for the resulting statistical parametric maps was thresholded at <italic>p</italic> &lt; 0.05 (FDR-corrected) with a cluster size &gt; 100 voxels.</p>
<p id="Par35">For the clusters showing significant between-group interactions, a 4-mm radius sphere was placed on the peak voxel, and the GM densities were extracted for regression analysis. To explore the clinical significance of the seed volume and the identified peak voxel volume, we used linear regression analysis to test the relationships with the neurobehavioral scores. The cognitive test scores served as the dependent variable. The threshold was set at <italic>p</italic> &lt; 0.05 with multiple corrections.</p>
</sec>
<sec id="Sec8">
<title>Statistical analysis</title>
<p id="Par36">Clinical and laboratory data were expressed as mean ± SD. The Mann-Whitney <italic>U</italic> test was used to compare levels of continuous variables of the G carriers and A homozygotes. Spearman’s correlation analysis adjusted for possible confounders was performed to assess associations between continuous variables. The interactions between two genotype groups in covariance strength and their 95% CIs were explored. All statistical analyses were conducted using IBM SPSS Statistics version 20 for Windows® software (IBM, Armonk, NY, USA). Statistical significance was set at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="Sec9" sec-type="results">
<title>Results</title>
<sec id="Sec10">
<title>Demographic data, cognitive data, and NPI</title>
<p id="Par37">The demographic and neurobehavioral characteristics of the Bcl-2 A homozygotes and G carriers are shown in Table <xref ref-type="table" rid="Tab1">1</xref>. The genotype distribution did not violate the Hardy-Weinberg principle (chi-square value = 1.65; <italic>p</italic> = 0.19). The G carriers had significantly higher scores in the Boston Naming Test, but the effects were not related to the categories of acetylcholinesterase inhibitors. The total NPI score in the A homozygotes (3.4 ± 5.1) was significantly lower than that in the G carriers (7.5 ± 9.4; <italic>p</italic> = 0.006). The significance was related to the subdomains of aggression (A homozygotes 0.04 ± 0.19; G carriers 0.5 ± 2.1; <italic>p</italic> = 0.04) and sleep (A homozygotes 0.8 ± 2.6; G carriers 2.7 ± 4.6; <italic>p</italic> = 0.009).</p>
</sec>
<sec id="Sec11">
<title>SCN patterns in the two genetic variants</title>
<p id="Par38">In all of the included patients, regions showing structural associations with the seed regions of each SCN were generally consistent with those reported in the literature [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>, Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Tables S1–S4). A direct comparison using voxel-based morphometry [<xref ref-type="bibr" rid="CR36">36</xref>] between the G carriers and A homozygotes showed no significant difference in GM volume with the threshold set at <italic>p</italic> &lt; 0.05, corrected for an FDR with a cluster size &gt; 100 voxels.<fig id="Fig1"><label>Fig. 1</label><caption><p>Statistical maps depict brain areas in which the gray matter intensity covaried with four target seeds for separate networks in (<bold>a</bold>) all patients with Alzheimer’s disease (<italic>n</italic> = 104), (<bold>b</bold>) G carriers (<italic>n</italic> = 76), and (<bold>c</bold>) A homozygotes (<italic>n</italic> = 28). Z-statistic maps (<italic>p</italic> &lt; 0.05, corrected with false discovery rate with extended cluster voxels &gt; 100). The images are displayed on a standard brain render. <italic>R</italic> Right; <italic>PCC</italic> Posterior cingulate cortex; <italic>FI</italic> Frontoinsular; <italic>Bcl-2</italic> B-cell chronic lymphocytic leukemia/lymphoma-2 gene (rs956572)</p></caption><graphic id="MO1" xlink:href="13195_2018_344_Fig1_HTML"></graphic></fig></p>
<p id="Par39">The SCN patterns in the G carriers and A homozygotes are presented in Fig. <xref ref-type="fig" rid="Fig1">1b and c</xref> and Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S5–S12. Interestingly, in the ECN, the A homozygotes had a considerably greater extent of structural covariance (number of voxels = 80,476) than the G carriers (number of voxels = 5673), although there were fewer cases in the A homozygote group. The SCNs of the GG, GA, and AA genotype groups are shown in Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S1.</p>
</sec>
<sec id="Sec12">
<title>Correlation analysis between seed volume and neurobehavioral scores in the two genotype groups</title>
<p id="Par40">Although the seed volumes were not significantly different between the G carriers and A homozygotes, correlation analysis suggested that the seed volumes played different roles in the two groups (Table <xref ref-type="table" rid="Tab2">2</xref>). For the G carriers, more cognitive domains showed significant correlations with the test scores in the entorhinal and frontoinsular seeds, whereas most of the cognitive tests were related to the volume of the DLPFC seed in the A homozygotes. For NPI scores, the clinical correlations with the seed volumes did not reach statistical significance.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Correlation coefficients between seed volume and cognitive test scores</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Seed region</th><th colspan="2">R Entorhinal</th><th colspan="2">L Posterior Cingulate</th><th colspan="2">R Frontoinsular</th><th colspan="2">R Dorsolateral prefrontal</th></tr><tr><th>MNI Coordinates</th><th colspan="2">(25,-9,-28)</th><th colspan="2">(-2,-36, 35)</th><th colspan="2">(38, 26,-10)</th><th colspan="2">(44, 36, 20)</th></tr><tr><th>Bcl-2 Genotypes</th><th>G-carriers</th><th>AA</th><th>G-carriers</th><th>AA</th><th>G-carriers</th><th>AA</th><th>G-carriers</th><th>AA</th></tr></thead><tbody><tr><td>Seed Volume</td><td>0.782</td><td>0.786</td><td>0.642</td><td>0.671</td><td>0.647</td><td>0.645</td><td>0.474</td><td>0.447</td></tr><tr><td>MMSE</td><td>0.220</td><td>
<italic>0.458</italic>
<sup>b</sup>
</td><td>
<italic>0.273</italic>
<sup>a</sup>
</td><td>0.191</td><td>0.135</td><td>0.123</td><td>-0.056</td><td>
<italic>0.571</italic>
<sup>b</sup>
</td></tr><tr><td>T1 to T4 trial scores</td><td>0.216</td><td>0.298</td><td>0.211</td><td>0.123</td><td>0.133</td><td>0.248</td><td>0.124</td><td>
<italic>0.559</italic>
<sup>b</sup>
</td></tr><tr><td>30 second recalls</td><td>
<italic>0.323</italic>
<sup>b</sup>
</td><td>0.204</td><td>0.204</td><td>0.278</td><td>0.180</td><td>0.296</td><td>0.073</td><td>
<italic>0.689</italic>
<sup>b</sup>
</td></tr><tr><td>10 minute recalls</td><td>
<italic>0.313</italic>
<sup>b</sup>
</td><td>0.213</td><td>0.193</td><td>0.100</td><td>0.087</td><td>0.123</td><td>-0.038</td><td>
<italic>0.484</italic>
<sup>b</sup>
</td></tr><tr><td>Modified Rey-Osterrieth Recall</td><td>0.179</td><td>
<italic>0.415</italic>
<sup>a</sup>
</td><td>0.188</td><td>0.120</td><td>0.168</td><td>0.243</td><td>-0.034</td><td>
<italic>0.478</italic>
<sup>a</sup>
</td></tr><tr><td>Modified Rey-Osterrieth Copy</td><td>-0.006</td><td>0.192</td><td>0.136</td><td>0.081</td><td>-0.009</td><td>0.271</td><td>-0.123</td><td>
<italic>0.505</italic>
<sup>b</sup>
</td></tr><tr><td>Visual object and Space Perception</td><td>-0.037</td><td>-0.006</td><td>0.058</td><td>-0.087</td><td>0.096</td><td>-0.204</td><td>-0.093</td><td>0.144</td></tr><tr><td>Semantic fluency: Animal</td><td>
<italic>0.298</italic>
<sup>a</sup>
</td><td>-0.002</td><td>0.101</td><td>0.141</td><td>0.167</td><td>0.041</td><td>0.068</td><td>
<italic>0.527</italic>
<sup>b</sup>
</td></tr><tr><td>Boston Naming Test</td><td>0.114</td><td>0.016</td><td>0.149</td><td>0.209</td><td>0.060</td><td>0.170</td><td>0.106</td><td>
<italic>0.459</italic>
<sup>a</sup>
</td></tr><tr><td>Comprehension</td><td>0.079</td><td>-0.106</td><td>0.253</td><td>0.179</td><td>0.126</td><td>0.106</td><td>0.234</td><td>0.342</td></tr><tr><td>Digit backward</td><td>-0.013</td><td>-0.018</td><td>0.139</td><td>0.164</td><td>-0.048</td><td>0.171</td><td>-0.090</td><td>0.227</td></tr><tr><td>Stroop Interference Correct</td><td>
<italic>0.381</italic>
<sup>b</sup>
</td><td>0.259</td><td>0.209</td><td>0.363</td><td>
<italic>0.398</italic>
<sup>b</sup>
</td><td>-0.009</td><td>
<italic>0.298</italic>
<sup>a</sup>
</td><td>
<italic>0.600</italic>
<sup>b</sup>
</td></tr><tr><td>Design fluency</td><td><italic>0.26</italic>5 <sup>a</sup></td><td>0.201</td><td>0.025</td><td>0.007</td><td>0.117</td><td>
<italic>0.495</italic>
<sup>a</sup>
</td><td>-0.079</td><td>
<italic>0.618</italic>
<sup>b</sup>
</td></tr><tr><td>Trail making test time</td><td>-0.162</td><td>-0.289</td><td>-0.168</td><td>-0.169</td><td>-0.048</td><td>-0.116</td><td>0.025</td><td>-<italic>0.516</italic>
<sup>b</sup></td></tr><tr><td>Correct line in Trail making</td><td>0.192</td><td>0.062</td><td>0.227</td><td>-0.023</td><td>
<italic>0.261</italic>
<sup>a</sup>
</td><td>0.160</td><td>-0.047</td><td>
<italic>0.497</italic>
<sup>b</sup>
</td></tr><tr><td>Neuropsychiatric Inventory</td><td>-0.023</td><td>-0.037</td><td>-0.103</td><td>-0.253</td><td>0.008</td><td>-0.117</td><td>-0.047</td><td>0.063</td></tr></tbody></table><table-wrap-foot><p>Numbers indicate Spearman correlation coefficients, <sup>a</sup><italic>p</italic> &lt; 0.05; <sup>b</sup>
<italic>p</italic> &lt;0.01</p><p><italic>MMSE</italic> Mini-Mental State Examination, <italic>MNI</italic> Montreal Neurological Institute, <italic>R</italic> right, <italic>L</italic> Left</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec13">
<title>Analysis of interactions in covariance strength</title>
<p id="Par41">We further explored interactions of the Bcl-2 genotypes with regard to differences in covariance strength. The relationships are shown in Fig. <xref ref-type="fig" rid="Fig2">2</xref> and Table <xref ref-type="table" rid="Tab3">3</xref>. Within the SCNs anchored to the right entorhinal seed, significant and increased structural covariance was observed in the A homozygotes compared with the G carriers (Table <xref ref-type="table" rid="Tab3">3</xref>, Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). The peak clusters showing interactions included the midoccipital and midfrontal regions as well as superior frontal clusters.<fig id="Fig2"><label>Fig. 2</label><caption><p>Peak clusters showing significant interactions of B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2) AA and G carriers from the (<bold>a</bold>) default mode network anchored by entorhinal cortex (AA &gt; G carriers); midline core subsystems with interactions of (<bold>b</bold>) AA &lt; G carriers or (<bold>c</bold>) AA &gt; G carriers; (<bold>d</bold>) executive control network by the dorsolateral prefrontal cortex (AA &gt; G carriers). (x, y, z) = Montreal Neurological Institute coordinates. G carriers: <italic>blue</italic>; AA genotype: <italic>green</italic>. The <italic>colored lines</italic> represent the covariance strengths between seed and peak cluster with 95% CIs as boundaries. <italic>GM</italic> Gray matter, <italic>R</italic> right, <italic>L</italic> Left</p></caption><graphic id="MO2" xlink:href="13195_2018_344_Fig2_HTML"></graphic></fig><table-wrap id="Tab3"><label>Table 3</label><caption><p>Interactions of Bcl-2 genotypes with pre-defined seed</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Seed</th><th rowspan="2">Peak regions</th><th></th><th colspan="3">Stereotaxic coordinates</th><th>Extent</th><th>Max T</th><th><italic>P</italic>-value</th></tr><tr><th>Side</th><th>x</th><th>y</th><th>z</th><th></th><th></th><th></th></tr></thead><tbody><tr><td colspan="9">Right entorhinal seed (Medial Temporal Subsystem of DMN)</td></tr><tr><td rowspan="3"> G- carriers &lt; AA</td><td>Mid-occipital</td><td>R</td><td>39</td><td>-66</td><td>24</td><td>288</td><td>4.34</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Mid-Frontal</td><td>R</td><td>29</td><td>29</td><td>34</td><td>869</td><td>3.98</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Superior Frontal</td><td>R</td><td>12</td><td>14</td><td>57</td><td>255</td><td>3.97</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td colspan="9">Left posterior cingulate seed (Medline Subsystem of DMN)</td></tr><tr><td rowspan="2"> G-carriers &gt; AA</td><td>Cerebellum area6</td><td>L</td><td>-33</td><td>-57</td><td>-21</td><td>928</td><td>4.41</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Cerebellum area6</td><td>L</td><td>-23</td><td>-55</td><td>-20</td><td>1137</td><td>4.32</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td> G-carriers &lt; AA</td><td>Sub-lobar</td><td>L</td><td>-23</td><td>8</td><td>13</td><td>596</td><td>4.77</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td colspan="9">Right frontoinsular seed (Salience Network)</td></tr><tr><td> G-carriers &lt; AA</td><td>Superior Frontal</td><td>R</td><td>18</td><td>54</td><td>22</td><td>191</td><td>3.85</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td colspan="9">Right dorsolateral prefrontal seed (Executive control network)</td></tr><tr><td rowspan="4"> G-carriers &lt; AA</td><td>Superior Frontal</td><td>R</td><td>14</td><td>41</td><td>39</td><td>930</td><td>4.69</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Superior Frontal</td><td>R</td><td>17</td><td>44</td><td>27</td><td>s.c.</td><td>4.64</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Superior Temporal pole</td><td>R</td><td>36</td><td>12</td><td>-21</td><td>747</td><td>4.32</td><td>
<italic>&lt;0.0001</italic>
</td></tr><tr><td>Superior Temporal pole</td><td>R</td><td>38</td><td>12</td><td>-21</td><td>280</td><td>3.91</td><td>
<italic>&lt;0.0001</italic>
</td></tr></tbody></table><table-wrap-foot><p><italic>SCN</italic> structural covariance network, <italic>DMN</italic> default mode network, <italic>s.c.</italic> same cluster</p></table-wrap-foot></table-wrap></p>
<p id="Par42">Within the SCNs anchored to the left PCC, increased structural associations in the G carriers included the cerebellum and middle temporal clusters (Table <xref ref-type="table" rid="Tab3">3</xref>; Fig. <xref ref-type="fig" rid="Fig2">2b</xref>, <italic>blue lines</italic>). Within the SCNs anchored to the left PCC seed, increased structural association in the A homozygotes was noted in the sublobar GM (Table <xref ref-type="table" rid="Tab3">3</xref>; Fig. <xref ref-type="fig" rid="Fig2">2c</xref>, <italic>green lines</italic>).</p>
<p id="Par43">For the right frontoinsular seed, an increased and significant correlation in the A homozygotes was found only in the superior frontal region (Table <xref ref-type="table" rid="Tab3">3</xref>). For the ECN, increased correlations in the A homozygotes were found in the superior frontal and temporal pole (Table <xref ref-type="table" rid="Tab3">3</xref>; Fig. <xref ref-type="fig" rid="Fig2">2d</xref>, <italic>green lines</italic>). For the aforementioned clusters, we found no dose-dependent effects in covariance strength when we compared the GG, GA, and AA genotype groups.</p>
</sec>
<sec id="Sec14">
<title>Correlations of peak cluster volumes with neurobehavioral test scores</title>
<p id="Par44">We then analyzed differences in the peak cluster volumes showing between-group interactions, of which the entorhinal seed anchored midfrontal peak clusters, frontoinsular seed-anchored superior-frontal peak cluster, and DLPFC-anchored superior-frontal peak cluster showed significantly greater volumes in the G carriers (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S13). For peak cluster volumes and neurobehavioral tests, we analyzed the clinical relationships of the G carriers (Table <xref ref-type="table" rid="Tab4">4</xref>) and A homozygotes (Table <xref ref-type="table" rid="Tab5">5</xref>) separately. In the G carriers, the significant peak clusters that correlated with the behavioral scores were mainly the PCC-anchored peak clusters. For the A homozygotes, significance was found in the DLPFC-anchored seed.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Significant Relationships between peak cluster volumes and clinical parameters (Bcl-2 G-carriers)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Seed region</th><th>EC</th><th>PCC</th><th>PCC</th><th>PCC</th><th>dLPFC</th></tr><tr><th>Peak cluster</th><th>Superior frontal</th><th>cerebellum</th><th>cerebellum</th><th>Sub-lobar</th><th>Superior frontal</th></tr><tr><th>Covariance strength relationship</th><th>G &lt; AA</th><th>G &gt; AA</th><th>G &gt; AA</th><th>G &lt; AA</th><th>G &lt; AA</th></tr></thead><tbody><tr><td>MNI coordinate</td><td>(12,14,57)</td><td>(-33,-57,-21)</td><td>(-23,-55,-20)</td><td>(-23,8,14)</td><td>(14,41,39)</td></tr><tr><td>Mini-mental state examination</td><td>0.017</td><td>0.340</td><td>
<italic>0.261</italic>
<sup>a</sup>
</td><td>-0.171</td><td>
<italic>-0.227</italic>
<sup>a</sup>
</td></tr><tr><td>T1 to T4 trial scores</td><td>-0.108</td><td>
<italic>0.374</italic>
<sup>b</sup>
</td><td>
<italic>0.291</italic>
<sup>a</sup>
</td><td>-0.159</td><td>-0.112</td></tr><tr><td>30 second recalls</td><td>-0.049</td><td>
<italic>0.362</italic>
<sup>b</sup>
</td><td>0.193</td><td>-0.104</td><td>-0.112</td></tr><tr><td>10 minute recalls</td><td>-0.037</td><td>
<italic>0.259</italic>
<sup>a</sup>
</td><td>0.197</td><td>-0.087</td><td>-0.192</td></tr><tr><td>Modified Rey-Osterrieth Recall</td><td>-0.040</td><td>
<italic>0.273</italic>
<sup>a</sup>
</td><td>0.177</td><td>-0.056</td><td>-0.118</td></tr><tr><td>Modified Rey-Osterrieth Copy</td><td>-0.115</td><td>
<italic>0.270</italic>
<sup>a</sup>
</td><td>0.181</td><td>-0.020</td><td>-0.090</td></tr><tr><td>Visual object and Space Perception</td><td>-0.009</td><td>0.178</td><td>-0.007</td><td>-0.059</td><td>-0.084</td></tr><tr><td>Semantic fluency: Animal</td><td>-0.119</td><td>
<italic>0.256</italic>
<sup>a</sup>
</td><td>0.161</td><td>-0.083</td><td>-0.206</td></tr><tr><td>Boston Naming Test</td><td>0.093</td><td>
<italic>0.374</italic>
<sup>b</sup>
</td><td>0.214</td><td>-0.073</td><td>-0.144</td></tr><tr><td>Comprehension</td><td>-0.045</td><td>
<italic>0.317</italic>
<sup>b</sup>
</td><td>
<italic>0.321</italic>
<sup>b</sup>
</td><td>
<italic>-0.420</italic>
<sup>b</sup>
</td><td>-0.148</td></tr><tr><td>Digit backward</td><td>0.006</td><td>0.268</td><td>0.198</td><td>
<italic>-0.240</italic>
<sup>a</sup>
</td><td>-0.112</td></tr><tr><td>Stroop Interference Correct</td><td>
<italic>-0.255</italic>
<sup>a</sup>
</td><td>0.234</td><td>0.152</td><td>-0.085</td><td>-0.118</td></tr><tr><td>Design fluency</td><td>0.058</td><td>0.228</td><td>0.049</td><td>-0.015</td><td>-0.113</td></tr><tr><td>Trail making test time</td><td>0.066</td><td>
<italic>-0.230</italic>
<sup>a</sup>
</td><td>-0.076</td><td>0.201</td><td>0.194</td></tr><tr><td>Correct line in Trail making</td><td>-0.139</td><td>
<italic>0.286</italic>
<sup>a</sup>
</td><td>0.181</td><td>-0.163</td><td>-0.074</td></tr><tr><td>Neuropsychiatric Inventory</td><td>-0.068</td><td>-0.050</td><td>-0.064</td><td>-0.042</td><td>0.197</td></tr></tbody></table><table-wrap-foot><p>Numbers indicate Spearman correlation coefficient; <sup>a</sup><italic>p</italic> &lt; 0.05; <sup>b</sup>
<italic>p</italic> &lt;0.01; <italic>EC</italic> entorinal cortex, <italic>PCC</italic> posterior cingulate cortex, <italic>dLPFC</italic> dorsolateral prefrontal cortex</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Significant Relationships between peak cluster volumes and clinical parameters (Bcl-2 AA)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Seed region</th><th>frontoinsular</th><th>dLPFC</th><th>dLPFC</th><th>dLPFC</th></tr><tr><th>Peak cluster</th><th>Superior frontal</th><th>Superior frontal</th><th>Superior temporal pole</th><th>temporal pole</th></tr><tr><th>Covariance strength relationship†</th><th>G &lt; AA</th><th>G &lt; AA</th><th>G &lt; AA</th><th>G &lt; AA</th></tr></thead><tbody><tr><td>MNI coordinate</td><td>(18,54,22)</td><td>(14,41,39)</td><td>(36,12,-21)</td><td>(38,12,-21)</td></tr><tr><td>Mini-mental state examination</td><td>0.295</td><td>0.273</td><td>0.270</td><td>
<italic>0.411</italic>
<sup>a</sup>
</td></tr><tr><td>T1 to T4 trial scores</td><td>
<italic>0.441</italic>
<sup>a</sup>
</td><td>0.103</td><td>0.189</td><td>0.291</td></tr><tr><td>30 second recalls</td><td>0.328</td><td>0.335</td><td>
<italic>0.378</italic>
<sup>a</sup>
</td><td>
<italic>0.432</italic>
<sup>a</sup>
</td></tr><tr><td>10 minute recalls</td><td>0.342</td><td>0.259</td><td>0.147</td><td>0.207</td></tr><tr><td>Modified Rey-Osterrieth Recall</td><td>
<italic>0.454</italic>
<sup>a</sup>
</td><td>0.245</td><td>0.205</td><td>0.364</td></tr><tr><td>Modified Rey-Osterrieth Copy</td><td>
<italic>0.441</italic>
<sup>a</sup>
</td><td>0.176</td><td>0.184</td><td>0.169</td></tr><tr><td>Visual object and Space Perception</td><td>0.045</td><td>0.068</td><td>-0.113</td><td>0.121</td></tr><tr><td>Semantic fluency: Animal</td><td>0.328</td><td>0.144</td><td>0.098</td><td>-0.005</td></tr><tr><td>Boston Naming Test</td><td>0.120</td><td>0.152</td><td>0.159</td><td>0.146</td></tr><tr><td>Comprehension</td><td>0.261</td><td>0.098</td><td>-0.022</td><td>-0.029</td></tr><tr><td>Digit backward</td><td>0.202</td><td>0.175</td><td>0.373</td><td>0.061</td></tr><tr><td>Stroop Interference Correct</td><td>0.399</td><td>
<italic>0.537</italic>
<sup>b</sup>
</td><td>0.253</td><td>0.324</td></tr><tr><td>Design fluency</td><td>0.363</td><td>-0.045</td><td>0.219</td><td>0.403</td></tr><tr><td>Trail making test time</td><td>-0.186</td><td>-0.299</td><td>-0.324</td><td>-<italic>0.520</italic>
<sup>b</sup></td></tr><tr><td>Correct line in Trail making</td><td>0.330</td><td>0.074</td><td>0.188</td><td>0.293</td></tr><tr><td>Neuropsychiatric Inventory</td><td>0.190</td><td>-0.131</td><td>-0.190</td><td>-0.038</td></tr></tbody></table><table-wrap-foot><p>Numbers indicate Spearman’s correlation coefficient; <italic>MNI</italic> Montreal Neurological Institute <sup>a</sup><italic>p</italic> &lt; 0.05; <sup>b</sup>
<italic>p</italic> &lt;0.01; <italic>dLPFC</italic> dorsolateral prefrontal cortex</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec15" sec-type="discussion">
<title>Discussion</title>
<p id="Par45">In this study, we analyzed differences between two Bcl-2 genotypes showing functional polymorphisms. The topography of the SCNs and clinical correlations also validated the different influences of the Bcl-2 genotype groups with regard to structural degeneration, which targeted the DMN midline subsystem in the G carriers and the ECN in the A homozygotes. The results support the hypothesis that network changes represent an endophenotype of the Bcl-2 polymorphism. In addition, the greater covariance strength of the AA genotype in all four networks suggests that covariance strength may serve as a putative biomarker for structural connectivity.</p>
<sec id="Sec16">
<title>Bcl-2 genotypes targeted different SCNs and modulated covariance strength</title>
<p id="Par46">Current neuroscience research supports the hypothesis that brain networks in AD can be influenced by environmental and biological interactions not limited to amyloid toxicity [<xref ref-type="bibr" rid="CR37">37</xref>] or network degenerative theory [<xref ref-type="bibr" rid="CR38">38</xref>]. Accordingly, cognitive functions are highly reflective of neuronal network changes. A number of studies have highlighted how genetic variations may affect brain organization and connectivity patterns [<xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR42">42</xref>]. Our results provide insight into the Bcl-2 genetic variants and their possible interference with structural covariance.</p>
<p id="Par47">Our SCN data suggest that genetic influences, in terms of network topography, were modulated differently by the two Bcl-2 genotypes. Spatial distributions revealed that the G carriers had more extended voxels in the DMN, whereas the A homozygotes had a larger structural association in the ECN. From a methodological perspective, the wider spatial extent in the G carriers may be partially driven by the larger number of cases. However, the correlation with clinical scores may validate the roles of DMN seed- or PCC-anchored peak clusters. The spatial extent of the SCN directly comparing the GG and GA genotype groups suggested that the SCN was not merely reflective of the number of cases. A further study with a larger sample size and an equal number of cases may help to elucidate our observations.</p>
<p id="Par48">We previously reported that stronger covariance strength between seed and peak clusters indicates more intranetwork connections [<xref ref-type="bibr" rid="CR43">43</xref>]. In a given genotype group, greater covariance strength may have indicated stronger associations between two interconnected clusters. In a degenerative model of AD, the pathological processes often lead to GM atrophy. Further longitudinal studies are needed to elucidate whether more intranetwork connections indicates faster degenerative processes.</p>
<p id="Par49">For the subsystems of the DMN, our results suggest that the genetic weighting may be higher in the PCC-anchored midline DMN system in the G carriers, because it was the only SCN showing G → AA genotypes in covariance strength. Previous studies have indicated that the AA genotype may be a risk factor for a smaller intracranial volume or worse clinical phenotype [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. We also found that covariance strength was higher in the AA genotype group and that the functional associations may have been more localized in the ECN. Several peak cluster volumes were also significantly smaller in the AA genotype group (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S13) than in the G carriers.</p>
<p id="Par50">The peak cluster represents regions that not only are anchored to the predefined seed but also show genotype group interactions in covariance strength. From a clinical point of view, the peak cluster may represent anatomical areas where genotype modulation occurs. Correlation analysis between the peak cluster volumes and clinical parameters was performed to establish the clinical significance; however, not all peak clusters were related to the clinical outcomes, and the peak clusters showing significant correlations were also different in each genotype group (Table <xref ref-type="table" rid="Tab4">4</xref> for G carriers; Table <xref ref-type="table" rid="Tab5">5</xref> for the AA genotype). With regard to the clinical implications, the peak cluster analysis suggested that the G carriers were more related to the SCN in the posterior brain regions, whereas the A homozygotes were more related to the anterior brain regions.</p>
</sec>
<sec id="Sec17">
<title>Clinical significance of executive control network in Bcl-2 A homozygotes</title>
<p id="Par51">In this study, seed regions, covariance strength, and peak clusters all supported the unique genetic effect of A homozygotes in the ECN. The ECN in our qualitative data consisted of the classic DLPFC and the parietal cortex [<xref ref-type="bibr" rid="CR13">13</xref>], and the increased A &gt; G interactions in the cortical hubs with associated clinical correlations supported its functional role. The Bcl-2 AA genotype has been associated with a reduced level of Bcl-2 [<xref ref-type="bibr" rid="CR6">6</xref>], whereas lower Bcl-2 protein and mRNA levels have been reported in the frontal cortex in bipolar disorders [<xref ref-type="bibr" rid="CR7">7</xref>]. Our observations may echo these findings [<xref ref-type="bibr" rid="CR21">21</xref>] and support the genetic associations of the AA genotype via its modulation of GM in the ECN in patients with AD. In this study, we also tested whether the A allele may have a dose-dependent effect on the covariance strength. Although the results were not significant, this insignificance may not fully reject the possible functional effect of the A allele, because only a small number of cases were included in this study, even though they fulfilled the Hardy-Weinberg principle.</p>
</sec>
<sec id="Sec18">
<title>Increased covariance strength in the DMN midtemporal subsystem in A homozygotes</title>
<p id="Par52">Although the medial frontal cortex has been shown to play a role in learning associations and the DLPFC has been shown to play a role in executive function, the coactivation of these prefrontal neural resources in AD has also been shown to compensate for posterior degenerative processes [<xref ref-type="bibr" rid="CR44">44</xref>]. Functional disconnection between the entorhinal seed and midfrontal regions, however, has been observed in AD [<xref ref-type="bibr" rid="CR45">45</xref>]. Although strong connections between the prefrontal cortex and the hippocampus may reinforce the learning and memory consolidation process, the integrated activity between these two regions tends to break down early in AD. If entorhinal-prefrontal connections represent compensatory mechanisms in the early stage of AD, the differences in covariance strength between two Bcl-2 genotype groups may have resulted in different brain reserves.</p>
</sec>
<sec id="Sec19">
<title>Bcl-2 G carriers and the relationships with the two DMN subsystems</title>
<p id="Par53">The genetic influence in the G carriers may have resulted in different genetic associations in the two DMN subsystems. The G genotype may have modulated the midline DMN subsystem because the PCC-anchored peak cluster volumes were related to more cognitive test domains showing statistical significance. The PCC-anchored DMN was also the only network to show greater covariance strength in the G carriers. Taken together, these findings suggest the unique role of the Bcl-2 G genotype group in the PCC-anchored DMN.</p>
<p id="Par54">In AD, the salient cognitive dysfunction is episodic memory impairment, which has been reported to be strongly associated with the hippocampal/entorhinal volume and the midtemporal DMN subsystem [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. The significant correlations of the entorhinal seed volumes and the clinical scores highlight the primary role of the entorhinal seed in the G carriers (Table <xref ref-type="table" rid="Tab2">2</xref>). In contrast, the entorhinal-anchored peak clusters were not predictive of cognitive scores.</p>
</sec>
<sec id="Sec20">
<title>Salience network and Bcl-2 G carriers</title>
<p id="Par55">In bipolar disorder [<xref ref-type="bibr" rid="CR21">21</xref>], a link between the anterior cingulate cortex, one of the key hubs in the salience network, and the salience network and Bcl-2 protein expression may exist. The role of the salience network has been suggested to support the processing of diverse homeostatically relevant internal and external stimuli [<xref ref-type="bibr" rid="CR48">48</xref>]. For the salience network analysis in this study, the seed frontoinsular region predicted scores on the Stroop test and the Trail Making Test, which were predominantly classified as external stimuli. Although the salience network was originally discovered to be related to internal emotional states [<xref ref-type="bibr" rid="CR13">13</xref>], our study did not establish a clinical role of the salience network in mediating NPI scores in either the G carriers or A homozygotes.</p>
</sec>
<sec id="Sec21">
<title>Study limitations</title>
<p id="Par56">Direct comparisons between the G carriers and A homozygotes showed between-group differences in NPI total scores, aggression, and sleep subscores. However, our network analysis did not find any relationships linking the SCNs to any of the significant clinical results. Because our study design used a seed-based approach, it is possible that the changes were mediated by different functional networks. The use of independent component analysis [<xref ref-type="bibr" rid="CR49">49</xref>] may help to overcome this limitation. Another important limitation of this study is that we did not include a control group, and the inclusion of a control group may have helped to elucidate whether the Bcl-2 functional polymorphisms exerted similar GM modulation patterns in healthy elderly subjects. However, associations between rs956572 functional polymorphisms and regional GM volume and functional states in healthy subjects have been reported [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. Given the differences in methods, sample sizes, and populations analyzed, it is difficult to compare our results directly with these reports. However, we found regional similarities in this study. Another potential limitation is that our seed-based analysis emphasized the SCNs that showed positive correlations with the seeds. Because the aim of this study was to test the hypothesis of the risk of different genotype groups, anticorrelation patterns suggestive of a compensatory process in each genotype group were not explored. Because clinical significance was established in restricted nodes showing covariance interactions, whether the seed or peak clusters imparted an equal amount of information within the whole network remains an important issue that needs to be investigated in future studies. Last, structural covariance data cannot be directly referred to as a connectivity or degenerative biomarker, although the patterns of SCN have been shown to mirror those of intrinsic connectivity patterns in healthy control subjects [<xref ref-type="bibr" rid="CR51">51</xref>]. Further studies with longitudinal cohorts are needed to validate the interpretation regarding greater covariance strength in the AA genotype and faster degeneration. In addition, to elucidate the functional effect of the A allele observed in this study, a larger sample cohort is required in future studies so that direct comparisons of the AA and GG genotypes with equal and adequate case numbers are possible.</p>
</sec>
</sec>
<sec id="Sec22" sec-type="conclusion">
<title>Conclusions</title>
<p id="Par57">In summary, the SCN analysis and covariance strength interactions support the genetic influences of the Bcl-2 rs956572 functional polymorphism on the SCN in the early stage of AD. We show a greater genetic influence in the A homozygotes on the ECN, whereas the genetic modulation in the G carriers was seen in the PCC-anchored midline DMN subsystem. We will investigate the biological meaning of covariance strength in future studies with longitudinal follow-up.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec23">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13195_2018_344_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p>Supplementary <bold>Tables S1–S13</bold>. (DOCX 67 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13195_2018_344_MOESM2_ESM.bmp"><label>Additional file 2: Figure S1.</label><caption><p>Structural covariance networks from four seed regions in GG, GA, and A homozygotes. According to the case numbers, the actual T value in AA was 5.529, GA = 4.924, and GG = 6.4612. (BMP 7288 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AD</term>
<def>
<p id="Par5">Alzheimer’s disease</p>
</def>
</def-item>
<def-item>
<term>ApoE</term>
<def>
<p id="Par6">Apolipoprotein E</p>
</def>
</def-item>
<def-item>
<term>BCL</term>
<def>
<p id="Par7">B-cell chronic lymphocytic leukemia/lymphoma-2</p>
</def>
</def-item>
<def-item>
<term>DLPFC</term>
<def>
<p id="Par8">Dorsolateral prefrontal cortex</p>
</def>
</def-item>
<def-item>
<term>DMN</term>
<def>
<p id="Par9">Default mode network</p>
</def>
</def-item>
<def-item>
<term>ECN</term>
<def>
<p id="Par10">Executive control network</p>
</def>
</def-item>
<def-item>
<term>FDR</term>
<def>
<p id="Par11">False discovery rate</p>
</def>
</def-item>
<def-item>
<term>GM</term>
<def>
<p id="Par12">Gray matter</p>
</def>
</def-item>
<def-item>
<term>MMSE</term>
<def>
<p id="Par13">Mini Mental State Examination</p>
</def>
</def-item>
<def-item>
<term>MNI</term>
<def>
<p id="Par14">Montreal Neurological Institute</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p id="Par15">Magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>mRNA</term>
<def>
<p id="Par16">Messenger RNA</p>
</def>
</def-item>
<def-item>
<term>NPI</term>
<def>
<p id="Par17">Neuropsychiatric Inventory</p>
</def>
</def-item>
<def-item>
<term>PCC</term>
<def>
<p id="Par18">Posterior cingulate cortex</p>
</def>
</def-item>
<def-item>
<term>ROI</term>
<def>
<p id="Par19">Region of interest</p>
</def>
</def-item>
<def-item>
<term>SCN</term>
<def>
<p id="Par20">Structural covariance network</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s13195-018-0344-4) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par58">This work was supported by grants CMRPG8C0571, CMRPG8D0771, and CMRPG8E0541 from Chang Gung Memorial Hospital, as well as by grant 104-2314-B-182A-026-MY2 from the National Science Council (to CCC) for MRI acquisition and genetic and clinical data collection and analysis.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par59">The datasets used and analyzed in the present study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>CCC and SJT conceived of and designed the study. CCC, YTC, CWH, SWH, SHH, CCLe, and CCLu acquired, analyzed, and interpreted data. CCC, YTC, and SJT drafted the manuscript. WNC, CYL, and CCLe performed the statistical analyses. CCC and SJT supervised the study. All authors contributed to critical revision of the manuscript for important intellectual content, and all authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par60">The study received approval from regional ethical committees at the Chang Gung Memorial Hospital and was carried out in accordance with the tenets of the Helsinki declaration. Written informed consent was obtained from all participants.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par61">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par62">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par63">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers</article-title>
<source/>Curr Opin Psychiatry
          <year>2006</year>
<volume>19</volume>
<fpage>313</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1097/01.yco.0000218604.63463.cd</pub-id>
<pub-id pub-id-type="pmid">16612219</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Martinou</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bcl-2 promotes regeneration of severed axons in mammalian CNS</article-title>
<source/>Nature
          <year>1997</year>
<volume>385</volume>
<fpage>434</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/385434a0</pub-id>
<pub-id pub-id-type="pmid">9009190</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tortosa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Bcl-2 and Bax protein expression in Alzheimer’s disease</article-title>
<source/>Acta Neuropathol
          <year>1998</year>
<volume>95</volume>
<fpage>407</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1007/s004010050817</pub-id>
<pub-id pub-id-type="pmid">9560019</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caraci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chisari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frasca</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Canonico</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Calafiore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bosco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Copani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sortino</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity</article-title>
<source/>Brain Res
          <year>2005</year>
<volume>1047</volume>
<fpage>30</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2005.04.004</pub-id>
<pub-id pub-id-type="pmid">15882840</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uemura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corson</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Perova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Warsh</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder</article-title>
<source/>Bipolar Disord
          <year>2011</year>
<volume>13</volume>
<fpage>41</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-5618.2011.00897.x</pub-id>
<pub-id pub-id-type="pmid">21320251</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machado-Vieira</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pivovarova</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Stanika</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zarate</surname>
<given-names>CA</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Drevets</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Brantner</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Baum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laje</surname>
<given-names>G</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor–mediated endoplasmic reticulum calcium release in subjects with bipolar disorder</article-title>
<source/>Biol Psychiatry
          <year>2011</year>
<volume>69</volume>
<fpage>344</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.10.019</pub-id>
<pub-id pub-id-type="pmid">21167476</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Schmid-Burgk</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Claus</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kornhuber</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>Increased serum glutamate in depressed patients</article-title>
<source/>Arch Psychiatr Nervenkr (1970)
          <year>1982</year>
<volume>232</volume>
<fpage>299</fpage>
<lpage>304</lpage>
<pub-id pub-id-type="doi">10.1007/BF00345492</pub-id>
<pub-id pub-id-type="pmid">6133511</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Effect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia</article-title>
<source/>Age (Dordr)
          <year>2013</year>
<volume>35</volume>
<fpage>343</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1007/s11357-011-9367-5</pub-id>
<pub-id pub-id-type="pmid">22198673</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Effect of Bcl-2 rs956572 polymorphism on age-related gray matter volume changes</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e56663</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056663</pub-id>
<pub-id pub-id-type="pmid">23437205</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Raichle</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging</article-title>
<source/>Nat Rev Neurosci
          <year>2007</year>
<volume>8</volume>
<fpage>700</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2201</pub-id>
<pub-id pub-id-type="pmid">17704812</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Amyloid burden in the hippocampus and default mode network: relationships with gray matter volume and cognitive performance in mild stage Alzheimer disease</article-title>
<source/>Medicine (Baltimore)
          <year>2015</year>
<volume>94</volume>
<fpage>e763</fpage>
<pub-id pub-id-type="doi">10.1097/MD.0000000000000763</pub-id>
<pub-id pub-id-type="pmid">25906109</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews-Hanna</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Reidler</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Sepulcre</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poulin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Buckner</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Functional-anatomic fractionation of the brain’s default network</article-title>
<source/>Neuron
          <year>2010</year>
<volume>65</volume>
<fpage>550</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.005</pub-id>
<pub-id pub-id-type="pmid">20188659</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Kenna</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Dissociable intrinsic connectivity networks for salience processing and executive control</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<fpage>2349</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5587-06.2007</pub-id>
<pub-id pub-id-type="pmid">17329432</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Supekar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Musen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Network analysis of intrinsic functional brain connectivity in Alzheimer’s disease</article-title>
<source/>PLoS Comput Biol
          <year>2008</year>
<volume>4</volume>
<fpage>e1000100</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1000100</pub-id>
<pub-id pub-id-type="pmid">18584043</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Gennatas</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Growdon</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Rabinovici</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease</article-title>
<source/>Brain
          <year>2010</year>
<volume>133</volume>
<fpage>1352</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awq075</pub-id>
<pub-id pub-id-type="pmid">20410145</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agosta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pievani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geroldi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Copetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frisoni</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Filippi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Resting state fMRI in Alzheimer’s disease: beyond the default mode network</article-title>
<source/>Neurobiol Aging
          <year>2012</year>
<volume>33</volume>
<fpage>1564</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.06.007</pub-id>
<pub-id pub-id-type="pmid">21813210</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filippi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Agosta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Scola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Canu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Magnani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marcone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Valsasina</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Caso</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Copetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cappa</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Falini</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Functional network connectivity in the behavioral variant of frontotemporal dementia</article-title>
<source/>Cortex
          <year>2013</year>
<volume>49</volume>
<fpage>2389</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1016/j.cortex.2012.09.017</pub-id>
<pub-id pub-id-type="pmid">23164495</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander-Bloch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giedd</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Bullmore</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Imaging structural co-variance between human brain regions</article-title>
<source/>Nat Rev Neurosci
          <year>2013</year>
<volume>14</volume>
<fpage>322</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3465</pub-id>
<pub-id pub-id-type="pmid">23531697</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spreng</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Structural covariance of the default network in healthy and pathological aging</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<fpage>15226</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2261-13.2013</pub-id>
<pub-id pub-id-type="pmid">24048852</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Bcl-2 associated with severity of manic symptoms in bipolar patients in a manic phase</article-title>
<source/>Psychiatry Res
          <year>2015</year>
<volume>225</volume>
<fpage>305</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2014.12.020</pub-id>
<pub-id pub-id-type="pmid">25563670</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soeiro-De-Souza</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Salvadore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Otaduy</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chaim</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Gattaz</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Zarate</surname>
<given-names>CA</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Machado-Vieira</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder</article-title>
<source/>Neuropsychopharmacology
          <year>2013</year>
<volume>38</volume>
<fpage>468</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.203</pub-id>
<pub-id pub-id-type="pmid">23072837</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer’s dementia</article-title>
<source/>Thromb Haemost
          <year>2015</year>
<volume>114</volume>
<fpage>1230</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1160/TH14-11-0938</pub-id>
<pub-id pub-id-type="pmid">26289958</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Jacova</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>DeKosky</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Barberger-Gateau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Delacourte</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frisoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Galasko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hampel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jicha</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Meguro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pasquier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rossor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salloway</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sarazin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Souza</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Scheltens</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Revising the definition of Alzheimer’s disease: a new lexicon</article-title>
<source/>Lancet Neurol
          <year>2010</year>
<volume>9</volume>
<fpage>1118</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(10)70223-4</pub-id>
<pub-id pub-id-type="pmid">20934914</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Terry</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Fuld</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Katzman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peck</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Pathological verification of ischemic score in differentiation of dementias</article-title>
<source/>Ann Neurol
          <year>1980</year>
<volume>7</volume>
<fpage>486</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1002/ana.410070516</pub-id>
<pub-id pub-id-type="pmid">7396427</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folstein</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>McHugh</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician</article-title>
<source/>J Psychiatr Res
          <year>1975</year>
<volume>12</volume>
<fpage>189</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/0022-3956(75)90026-6</pub-id>
<pub-id pub-id-type="pmid">1202204</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PN</given-names>
</name>
</person-group>
<article-title>Validating the Chinese version of the Verbal Learning Test for screening Alzheimer’s disease</article-title>
<source/>J Int Neuropsychol Soc
          <year>2010</year>
<volume>16</volume>
<fpage>244</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1017/S1355617709991184</pub-id>
<pub-id pub-id-type="pmid">20003579</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boone</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>The Boston Qualitative Scoring System for the Rey-Osterrieth Complex Figure</article-title>
<source/>J Clin Exp Neuropsychol
          <year>2000</year>
<volume>22</volume>
<fpage>430</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1076/1380-3395(200006)22:3;1-V;FT430</pub-id>
<pub-id pub-id-type="pmid">10979748</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Goodglass</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Weintraub</surname>
<given-names>S</given-names>
</name>
</person-group>
<source/>The Boston Naming Test
          <year>1983</year>
<publisher-loc>Philadelphia</publisher-loc>
<publisher-name>Lea &amp; Febiger</publisher-name>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Warrington</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>James</surname>
<given-names>M</given-names>
</name>
</person-group>
<source/>Visual Object and Space Perception Battery. Bury St
          <year>1991</year>
<publisher-loc>Edmunds, UK</publisher-loc>
<publisher-name>Thames Valley Test Co.</publisher-name>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>PN</given-names>
</name>
</person-group>
<article-title>Patterns of executive dysfunction in amnestic mild cognitive impairment</article-title>
<source/>Int Psychogeriatr
          <year>2013</year>
<volume>25</volume>
<fpage>1181</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1017/S1041610213000392</pub-id>
<pub-id pub-id-type="pmid">23574879</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mega</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rosenberg-Thompson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carusi</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Gornbein</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia</article-title>
<source/>Neurology
          <year>1994</year>
<volume>44</volume>
<fpage>2308</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.44.12.2308</pub-id>
<pub-id pub-id-type="pmid">7991117</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuingnet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gerardin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tessieras</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Auzias</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lehericy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Habert</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Chupin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Benali</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Colliot</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Automatic classification of patients with Alzheimer’s disease from structural MRI: a comparison of ten methods using the ADNI database</article-title>
<source/>Neuroimage
          <year>2011</year>
<volume>56</volume>
<fpage>766</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.06.013</pub-id>
<pub-id pub-id-type="pmid">20542124</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhardt</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Worsley</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Besson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Concha</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Bernasconi</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Mapping limbic network organization in temporal lobe epilepsy using morphometric correlations: insights on the relation between mesiotemporal connectivity and cortical atrophy</article-title>
<source/>Neuroimage
          <year>2008</year>
<volume>42</volume>
<fpage>515</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.04.261</pub-id>
<pub-id pub-id-type="pmid">18554926</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zielinski</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Froehlich</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Prigge</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Cooperrider</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cariello</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bigler</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Lainhart</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>scMRI reveals large-scale brain network abnormalities in autism</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e49172</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049172</pub-id>
<pub-id pub-id-type="pmid">23185305</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Menon</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2004</year>
<volume>101</volume>
<fpage>4637</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0308627101</pub-id>
<pub-id pub-id-type="pmid">15070770</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashburner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Friston</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Voxel-based morphometry—the methods</article-title>
<source/>Neuroimage
          <year>2000</year>
<volume>11</volume>
<fpage>805</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1006/nimg.2000.0582</pub-id>
<pub-id pub-id-type="pmid">10860804</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hampel</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Amyloid-β and cognition in aging and Alzheimer’s disease: molecular and neurophysiological mechanisms</article-title>
<source/>J Alzheimers Dis
          <year>2013</year>
<volume>33</volume>
<issue>Suppl 1</issue>
<fpage>S79</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">22531423</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jack</surname>
<given-names>CR</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Lowe</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Weigand</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Wiste</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Senjem</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Knopman</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Shiung</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Boeve</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<fpage>1355</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp062</pub-id>
<pub-id pub-id-type="pmid">19339253</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chhatwal</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Benzinger</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Jack</surname>
<given-names>C</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Ances</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Salloway</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Ringman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Koeppe</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Marcus</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Brickman</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>McDade</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fagan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Goate</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buckles</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Sperling</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Impaired default network functional connectivity in autosomal dominant Alzheimer disease</article-title>
<source/>Neurology
          <year>2013</year>
<volume>81</volume>
<fpage>736</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a1aafe</pub-id>
<pub-id pub-id-type="pmid">23884042</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Zalesky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder</article-title>
<source/>Hum Brain Mapp
          <year>2015</year>
<volume>36</volume>
<fpage>367</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.22634</pub-id>
<pub-id pub-id-type="pmid">25201318</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Glahn</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Jahanshad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Genetics of the connectome</article-title>
<source/>Neuroimage
          <year>2013</year>
<volume>80</volume>
<fpage>475</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.05.013</pub-id>
<pub-id pub-id-type="pmid">23707675</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeidan-Chulia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>De Oliveira</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Casanova</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Gelain</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Verkhratsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Altered expression of Alzheimer’s disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy</article-title>
<source/>Cell Death Dis
          <year>2014</year>
<volume>5</volume>
<fpage>e1250</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2014.227</pub-id>
<pub-id pub-id-type="pmid">24853428</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Mu-En</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer’s disease</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<fpage>54200</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">27494844</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grady</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>McIntosh</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Beig</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keightley</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Burian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer’s disease</article-title>
<source/>J Neurosci
          <year>2003</year>
<volume>23</volume>
<fpage>986</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">12574428</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Changes in hippocampal connectivity in the early stages of Alzheimer’s disease: evidence from resting state fMRI</article-title>
<source/>Neuroimage
          <year>2006</year>
<volume>31</volume>
<fpage>496</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.12.033</pub-id>
<pub-id pub-id-type="pmid">16473024</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Dutt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>The Chinese Verbal Learning Test specifically assesses hippocampal state</article-title>
<source/>Am J Alzheimers Dis Other Demen
          <year>2015</year>
<volume>30</volume>
<fpage>412</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1177/1533317514552667</pub-id>
<pub-id pub-id-type="pmid">25270640</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WN</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Clinical significance of cerebrovascular biomarkers and white matter tract integrity in Alzheimer disease: clinical correlations with neurobehavioral data in cross-sectional and after 18 months follow-ups</article-title>
<source/>Medicine (Baltimore)
          <year>2015</year>
<volume>94</volume>
<fpage>e1192</fpage>
<pub-id pub-id-type="doi">10.1097/MD.0000000000001192</pub-id>
<pub-id pub-id-type="pmid">26181568</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Allman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Carlin</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Macedo</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Dearmond</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution</article-title>
<source/>Alzheimer Dis Assoc Disord
          <year>2007</year>
<volume>21</volume>
<fpage>S50</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1097/WAD.0b013e31815c0f14</pub-id>
<pub-id pub-id-type="pmid">18090425</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beckmann</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Deluca</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Investigations into resting-state connectivity using independent component analysis</article-title>
<source/>Philos Trans R Soc Lond B Biol Sci
          <year>2005</year>
<volume>360</volume>
<fpage>1001</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2005.1634</pub-id>
<pub-id pub-id-type="pmid">16087444</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvadore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nugent</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Akula</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Zarate</surname>
<given-names>CA</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>McMahon</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Manji</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Drevets</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans</article-title>
<source/>Biol Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>804</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.05.025</pub-id>
<pub-id pub-id-type="pmid">19589501</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seeley</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Greicius</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Neurodegenerative diseases target large-scale human brain networks</article-title>
<source/>Neuron
          <year>2009</year>
<volume>62</volume>
<fpage>42</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.024</pub-id>
<pub-id pub-id-type="pmid">19376066</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>